Clinical Trials Arena on MSN10h
Anocca gains European authorisation for Phase I/II trial of pancreatic cancer drugThe trial’s first phase will begin in university hospitals across the Netherlands, Denmark, Germany and Sweden.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback